Morgan Stanley
IBB icon

Morgan Stanley’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$458M Buy
3,620,795
+817,621
+29% +$103M 0.03% 535
2025
Q1
$359M Sell
2,803,174
-674,423
-19% -$86.3M 0.03% 588
2024
Q4
$460M Buy
3,477,597
+316,150
+10% +$41.8M 0.03% 499
2024
Q3
$460M Buy
3,161,447
+438,850
+16% +$63.9M 0.03% 498
2024
Q2
$374M Buy
2,722,597
+18,043
+0.7% +$2.48M 0.03% 554
2024
Q1
$371M Sell
2,704,554
-2,438,542
-47% -$335M 0.03% 552
2023
Q4
$699M Buy
5,143,096
+2,211,048
+75% +$300M 0.03% 537
2023
Q3
$359M Sell
2,932,048
-20,865
-0.7% -$2.55M 0.04% 476
2023
Q2
$375M Buy
2,952,913
+30,107
+1% +$3.82M 0.04% 466
2023
Q1
$378M Sell
2,922,806
-187,940
-6% -$24.3M 0.04% 447
2022
Q4
$408M Sell
3,110,746
-598,056
-16% -$78.5M 0.05% 402
2022
Q3
$434M Buy
3,708,802
+614,552
+20% +$71.9M 0.06% 309
2022
Q2
$364M Buy
3,094,250
+18,639
+0.6% +$2.19M 0.05% 374
2022
Q1
$401M Sell
3,075,611
-724,234
-19% -$94.4M 0.05% 319
2021
Q4
$580M Buy
3,799,845
+464,222
+14% +$70.8M 0.07% 256
2021
Q3
$539M Sell
3,335,623
-34,441
-1% -$5.57M 0.07% 248
2021
Q2
$552M Sell
3,370,064
-2,696,319
-44% -$441M 0.07% 246
2021
Q1
$913M Sell
6,066,383
-2,106,329
-26% -$317M 0.13% 164
2020
Q4
$1.24B Buy
8,172,712
+1,100,694
+16% +$167M 0.19% 122
2020
Q3
$958M Buy
7,072,018
+1,823,668
+35% +$247M 0.19% 126
2020
Q2
$717M Sell
5,248,350
-349,498
-6% -$47.8M 0.16% 144
2020
Q1
$603M Buy
5,597,848
+327,597
+6% +$35.3M 0.16% 135
2019
Q4
$635M Buy
5,270,251
+1,721,446
+49% +$207M 0.15% 142
2019
Q3
$353M Sell
3,548,805
-37,524
-1% -$3.73M 0.09% 212
2019
Q2
$391M Sell
3,586,329
-606,558
-14% -$66.2M 0.1% 192
2019
Q1
$469M Sell
4,192,887
-12,947
-0.3% -$1.45M 0.13% 166
2018
Q4
$406M Buy
4,205,834
+179,724
+4% +$17.3M 0.12% 175
2018
Q3
$491M Buy
4,026,110
+143,209
+4% +$17.5M 0.12% 167
2018
Q2
$426M Sell
3,882,901
-47,294
-1% -$5.19M 0.12% 181
2018
Q1
$420M Buy
3,930,195
+225,610
+6% +$24.1M 0.12% 172
2017
Q4
$396M Buy
3,704,585
+1,941,257
+110% +$207M 0.11% 191
2017
Q3
$588M Sell
1,763,328
-313,392
-15% -$105M 0.18% 125
2017
Q2
$644M Buy
2,076,720
+302,215
+17% +$93.7M 0.19% 114
2017
Q1
$520M Buy
1,774,505
+248,914
+16% +$73M 0.16% 136
2016
Q4
$405M Buy
1,525,591
+169,913
+13% +$45.1M 0.13% 162
2016
Q3
$392M Buy
1,355,678
+483,703
+55% +$140M 0.13% 157
2016
Q2
$224M Sell
871,975
-551,171
-39% -$142M 0.08% 268
2016
Q1
$371M Sell
1,423,146
-414,232
-23% -$108M 0.14% 164
2015
Q4
$622M Sell
1,837,378
-768,761
-29% -$260M 0.23% 99
2015
Q3
$791M Buy
2,606,139
+756,219
+41% +$229M 0.29% 58
2015
Q2
$683M Sell
1,849,920
-182,917
-9% -$67.5M 0.24% 82
2015
Q1
$698M Buy
2,032,837
+251,957
+14% +$86.5M 0.26% 78
2014
Q4
$540M Sell
1,780,880
-561,164
-24% -$170M 0.2% 114
2014
Q3
$641M Buy
2,342,044
+111,269
+5% +$30.4M 0.25% 82
2014
Q2
$573M Buy
2,230,775
+281,537
+14% +$72.4M 0.22% 86
2014
Q1
$461M Buy
1,949,238
+888,467
+84% +$210M 0.19% 114
2013
Q4
$241M Sell
1,060,771
-9,374
-0.9% -$2.13M 0.1% 221
2013
Q3
$224M Sell
1,070,145
-470,621
-31% -$98.6M 0.11% 211
2013
Q2
$268M Buy
+1,540,766
New +$268M 0.14% 184